|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 51/00 | (2006.01) |
| A61K 39/42 | (2006.01) | ||
| A61K 39/40 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/42 | (2017.01) |
| (11) | Number of the document | 2985039 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15185714.1 |
| Date of filing the European patent application | 2005-03-03 | |
| (97) | Date of publication of the European application | 2016-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (30) | Number | Date | Country code |
| 550015 P | 2004-03-03 | US |
| (72) |
Dake, Michael D., US
Waugh, Jacob M., US
|
| (73) |
ReVance Therapeutics, Inc.,
7555 Gateway Blvd., Newark, CA 94560,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Botulino toksinų vietinis taikymas ir jų įvedimas per odą |
| TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
| Payment date | Validity (years) | Amount | |
| 2021-02-18 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-03-03 |